http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2393746-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_312600ed06c663e841ffcf1cbc7952f4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 |
| filingDate | 2006-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_745ec58b48a5b4f72ae48bf31956c437 |
| publicationDate | 2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2393746-T3 |
| titleOfInvention | Use of glycosylated hydroxystilbenes for the prevention and treatment of eye diseases |
| abstract | Use of resveratrol-3-O-1-mono-D-glycoside (piceido) for the production of a pharmaceutical / nutritional preparation for the prevention and treatment of corneal mist formation and delayed epithelial healing of the cornea after refractive surgery and for the treatment of erosions and lesions of the cornea, in which said conditions of the eye imply an imbalance in the production of TGF-1 in the affected site. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018096196-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11213536-B2 |
| priorityDate | 2005-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 483.